Down 20% in 2026, is now the time to buy CSL shares?

MotleyFool12:54

The CSL Ltd (ASX: CSL) share price is heading south today, with the biotech giant continuing a difficult run. At the time of writing, the CSL share price is down 1.91% to $135.37, after falling as low...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2620699215?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 12:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620699215","market":"nz","top_or_hot":-1,"title":"Down 20% in 2026, is now the time to buy CSL shares?","media":"MotleyFool","content":"<div>\n<p>The CSL Ltd (ASX: CSL) share price is heading south today, with the biotech giant continuing a difficult run.\nAt the time of writing, the CSL share price is down 1.91% to $135.37, after falling as low...</p>\n\n<a href=\"https://www.fool.com.au/2026/03/19/down-20-in-2026-is-now-the-time-to-buy-csl-shares/\">Source Link</a>\n\n</div>\n","source":"motleyfoolau_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Down 20% in 2026, is now the time to buy CSL shares?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDown 20% in 2026, is now the time to buy CSL shares?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-19 12:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com.au/2026/03/19/down-20-in-2026-is-now-the-time-to-buy-csl-shares/><strong>MotleyFool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The CSL Ltd (ASX: CSL) share price is heading south today, with the biotech giant continuing a difficult run.\nAt the time of writing, the CSL share price is down 1.91% to $135.37, after falling as low...</p>\n\n<a href=\"https://www.fool.com.au/2026/03/19/down-20-in-2026-is-now-the-time-to-buy-csl-shares/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1169590202.USD","symbol_name":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","start_time":0,"source_url":"https://www.fool.com.au/2026/03/19/down-20-in-2026-is-now-the-time-to-buy-csl-shares/","article_id":"2620699215","we_media_id":null,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/19/down-20-in-2026-is-now-the-time-to-buy-csl-shares/","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2620699215","pubTimestamp":1773896095,"columns":[],"sourceInfo":{"source_id":"motleyfoolau_stock","name":"MotleyFool"},"weMediaInfo":null,"summary":"TheCSL Ltd share price is heading south today, with the biotech giant continuing a difficult run.At the time of writing, the CSL share price is down 1.91% to $135.37, after falling as low as $133.35 earlier in the session. That marks a new multi-year low, with the stock last trading at these levels back in September 2017.The decline means CSL shares are now down around 22% in 2026. This raises the question of whether this is a buying opportunity or if the share price has further to fall.Over the past year, the stock has consistently made lower highs and lower lows. The latest move to multi-year lows reinforces that trend, with no clear signs of a reversal.At the same time, the share price is trading well below key moving averages, which tell us sellers are still in control.At the same time, broader market conditions have not helped. Healthcare stocks have lagged in 2026, while investors have shifted towards sectors such as resources and energy.That means the next move will likely depen","collect":0,"end_time":0,"defaultTopTitle":"fool.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","BK4150":"赌场与赌博","LU0728928796.USD":"abrdn SICAV I - GLOBAL SMALL&MID-CAP SDG HORIZONS EQUITY \"A\" (USD) ACC","BK4086":"建筑产品","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","CSL":"卡莱尔伙伴","RSI":"Rush Street Interactive, Inc.","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","BK7511":"ESG概念","BK7067":"生物科技","CSL.AU":"CSL LIMITED","BK7508":"医药生物股","BK7501":"新冠治疗股"},"translate_title":"2026年下跌20%，现在是购买CSL股票的时候吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSL.AU":1.5,"RSI":1,"CSL":1.5},"content_text":"The CSL Ltd (ASX: CSL) share price is heading south today, with the biotech giant continuing a difficult run.\nAt the time of writing, the CSL share price is down 1.91% to $135.37, after falling as low as $133.35 earlier in the session. That marks a new multi-year low, with the stock last trading at these levels back in September 2017. \nThe decline means CSL shares are now down around 22% in 2026. This raises the question of whether this is a buying opportunity or if the share price has further to fall.\nLet's take a closer look.\nImage source: Getty Images\nA prolonged downtrend continues\nCSL's share price has been trending lower for some time, and recent trading suggests momentum remains weak.\nOver the past year, the stock has consistently made lower highs and lower lows. The latest move to multi-year lows reinforces that trend, with no clear signs of a reversal.\nFrom a technical perspective, indicators remain soft. The relative strength index (RSI) has been hovering in the low range, pointing to weak buying pressure rather than strong accumulation.\nAt the same time, the share price is trading well below key moving averages, which tell us sellers are still in control.\nThe next key level to watch is around the $130 mark, which may act as near-term support. On the upside, previous support near $150 could now act as resistance if the stock attempts to recover.\nWhat is driving the weakness?\nCSL has faced slower growth expectations in parts of its business, particularly in its vaccine division. Reduced vaccination demand and changes in global health trends have weighed on sentiment.\nThere have also been concerns around margins, with rising costs and pricing pressures affecting earnings expectations.\nAt the same time, broader market conditions have not helped. Healthcare stocks have lagged in 2026, while investors have shifted towards sectors such as resources and energy.\nThis rotation has left CSL out of favour with investors, despite its strong long-term track record.\nIs this a buying opportunity?\nDespite the recent weakness, CSL remains one of Australia's largest and most established healthcare companies.\nThe business has a global footprint, strong positions in plasma therapies and vaccines, and a long track record of growth.\nAfter the recent pullback, valuation is starting to come into focus. Some investors may see value at these levels, especially given CSL's history.\nHowever, the trend is still pointing lower. Until earnings stabilise and sentiment improves, the share price could remain under pressure.\nFoolish takeaway\nCSL shares have fallen to levels not seen in almost a decade, highlighting how much sentiment has changed.\nThe sell-off has made the stock look cheaper, but the trend is still pointing lower.\nThat means the next move will likely depend on whether CSL can rebuild confidence in its growth outlook over the coming months.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2620699215","isCrawlerRequest":true}